A systematic review and meta-analysis conducted by Hay et al published in Arthritis Care and Research reported that there was no significant association between allopurinol use and all-cause mortality in patients with gout (adjusted hazard ratio = 0.8 and 95 % confidence interval= 0.60-1.05).1 This meta-analysis is technically sound and the data support the conclusions. Some points are discussed.